RxDoctor Payments Data

Kirasten Brasfield, MD

Family Medicine · Chatsworth, GANPI 1861998460

Payments from drug & device makers

$3,373in general payments, 2019–2025

Across 210 payments — averaging $16.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$770
  • Novo Nordisk$579
  • Lilly USA, LLC$261
  • Amgen$221
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$192
  • GSK$125
  • plus $1K from 25 others

What the payments were for

  • Food & beverage$3,373100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,373 in reported general payments places this provider in the 75th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$54,197
Medicare patients
195
Services billed
1,782

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide222$282,897
OzempicSemaglutide187$242,839
JardianceEmpagliflozin137$110,279
Trelegy ElliptaFluticasone/Umeclidin/Vilanter141$103,076
XareltoRivaroxaban74$61,968
EliquisApixaban73$59,053
RybelsusSemaglutide35$47,058
TrulicityDulaglutide25$43,926
GemtesaVibegron57$35,961
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog30$30,243
FarxigaDapagliflozin Propanediol34$29,277
RexultiBrexpiprazole14$20,639
Combivent RespimatIpratropium/Albuterol Sulfate17$20,192
LinzessLinaclotide25$19,242
VraylarCariprazine Hcl12$19,231

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$261$326,823247 claims
Novo NordiskOzempic, Rybelsus$579$289,897222 claims
Boehringer IngelheimJardiance, Combivent Respimat, Tradjenta, Synjardy Xr, Stiolto Respimat$63$159,218194 claims
GSKTrelegy Ellipta, Anoro Ellipta$125$110,202155 claims
Johnson & JohnsonXarelto$19$61,96874 claims
PfizerEliquis$80$59,05373 claims
AstraZenecaFarxiga, Symbicort, Breztri Aerosphere, Bevespi Aerosphere$72$58,410114 claims
AbbVieLinzess, Vraylar$770$38,47337 claims
Sumitomo Pharma America, Inc.Gemtesa$38$35,96157 claims
Otsuka America Pharmaceutical, Inc.Rexulti$24$20,63914 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$120$17,83015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Chatsworth

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →